Skip to main content

Advertisement

Fig. 1 | Critical Care

Fig. 1

From: Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants

Fig. 1

Hemochron® Signature POCT results (lines 1 to 4) plotted against concentrations of a apixaban, b rivaroxaban, and c dabigatran. Line 1: prothrombin time/international normalized ratio (PT/INR) POCT; line 2: activated partial thromboplastin time (aPTT) POCT; line 3: activated clotting time-low range (ACT-LR) POCT; line 4: ACT+ POCT. n = 118 samples for rivaroxaban, n = 117 samples for apixaban, and n = 168 samples for dabigatran

Back to article page